Kytopen

Cambridge, United States

Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.

Apr 2026

Series B

Top Investors

National Science FoundationMerckAlexandria Venture InvestmentsThe EngineMassachusetts Clean Energy Center

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Kytopen's investors?

Kytopen's investors include National Science Foundation, Merck, Alexandria Venture Investments, The Engine, Massachusetts Clean Energy Center.

Where is Kytopen headquartered?

Kytopen is headquartered in Cambridge, United States.

What does Kytopen do?

Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.

What stage is Kytopen at?

Kytopen is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2026.

MLA

"Kytopen — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/kytopen. Accessed June 3, 2026.

APA

VCBacked. (2026). Kytopen — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/kytopen

Wikipedia (cite web)

{{cite web |title=Kytopen — Funding & Investors |url=https://www.vcbacked.co/company/kytopen |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2026.